- Home
- FMY vs ABVC Comparison
FMY vs ABVC Comparison
Compare FMY & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMY
- ABVC
- Stock Information
- Founded
- FMY 2005
- ABVC 2015
- Country
- FMY United States
- ABVC United States
- Employees
- FMY N/A
- ABVC N/A
- Industry
- FMY Finance/Investors Services
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- FMY Finance
- ABVC Health Care
- Exchange
- FMY Nasdaq
- ABVC Nasdaq
- Market Cap
- FMY 51.6M
- ABVC 52.1M
- IPO Year
- FMY N/A
- ABVC N/A
- Fundamental
- Price
- FMY $12.08
- ABVC $2.91
- Analyst Decision
- FMY
- ABVC
- Analyst Count
- FMY 0
- ABVC 0
- Target Price
- FMY N/A
- ABVC N/A
- AVG Volume (30 Days)
- FMY 10.1K
- ABVC 84.1K
- Earning Date
- FMY 01-01-0001
- ABVC 11-13-2025
- Dividend Yield
- FMY 6.98%
- ABVC N/A
- EPS Growth
- FMY N/A
- ABVC N/A
- EPS
- FMY N/A
- ABVC N/A
- Revenue
- FMY N/A
- ABVC $391,242.00
- Revenue This Year
- FMY N/A
- ABVC $735.18
- Revenue Next Year
- FMY N/A
- ABVC N/A
- P/E Ratio
- FMY N/A
- ABVC N/A
- Revenue Growth
- FMY N/A
- ABVC 186.84
- 52 Week Low
- FMY $10.71
- ABVC $0.40
- 52 Week High
- FMY $12.17
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- FMY 36.19
- ABVC 47.60
- Support Level
- FMY $12.10
- ABVC $2.86
- Resistance Level
- FMY $12.16
- ABVC $3.05
- Average True Range (ATR)
- FMY 0.10
- ABVC 0.15
- MACD
- FMY -0.01
- ABVC -0.02
- Stochastic Oscillator
- FMY 0.00
- ABVC 26.59
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.